生物共轭抗体-特洛伊免疫转换器通过对髓系细胞进行程序化两步免疫调节，以最小的毒性增强癌症免疫疗法（Adv. Healthcare Mater.）

IF 10 2区医学 Q1 ENGINEERING, BIOMEDICAL Advanced Healthcare Materials Pub Date : 2024-10-28 DOI:10.1002/adhm.202470171

Soyoung Park, Seung Mo Jin, Suhyeon Kim, Ju Hee Cho, JungHyub Hong, Yong-Soo Bae, Yong Taik Lim

{"title":"生物共轭抗体-特洛伊免疫转换器通过对髓系细胞进行程序化两步免疫调节，以最小的毒性增强癌症免疫疗法（Adv. Healthcare Mater.）","authors":"Soyoung Park, Seung Mo Jin, Suhyeon Kim, Ju Hee Cho, JungHyub Hong, Yong-Soo Bae, Yong Taik Lim","doi":"10.1002/adhm.202470171","DOIUrl":null,"url":null,"abstract":"<p><b>Antibody-Trojan Immune Converter</b></p><p>In article 2401270 by Yong Taik Lim and co-worker, a programmed two-step activation strategy is suggested to enhance cancer immunotherapy with minimized systemic toxicities via Antibody-Trojan Immune Converter Conjugates that specifically targets myeloid cells by anti-SIRPα followed by reactivation of transiently inactivated Trojan TLR7/8 agonist after antibody-mediated endocytosis.\n\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":113,"journal":{"name":"Advanced Healthcare Materials","volume":"13 27","pages":""},"PeriodicalIF":10.0000,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adhm.202470171","citationCount":"0","resultStr":"{\"title\":\"Bioconjugated Antibody-Trojan Immune Converter Enhance Cancer Immunotherapy with Minimized Toxicity by Programmed Two-Step Immunomodulation of Myeloid Cells (Adv. Healthcare Mater. 27/2024)\",\"authors\":\"Soyoung Park, Seung Mo Jin, Suhyeon Kim, Ju Hee Cho, JungHyub Hong, Yong-Soo Bae, Yong Taik Lim\",\"doi\":\"10.1002/adhm.202470171\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><b>Antibody-Trojan Immune Converter</b></p><p>In article 2401270 by Yong Taik Lim and co-worker, a programmed two-step activation strategy is suggested to enhance cancer immunotherapy with minimized systemic toxicities via Antibody-Trojan Immune Converter Conjugates that specifically targets myeloid cells by anti-SIRPα followed by reactivation of transiently inactivated Trojan TLR7/8 agonist after antibody-mediated endocytosis.\\n\\n <figure>\\n <div><picture>\\n <source></source></picture><p></p>\\n </div>\\n </figure></p>\",\"PeriodicalId\":113,\"journal\":{\"name\":\"Advanced Healthcare Materials\",\"volume\":\"13 27\",\"pages\":\"\"},\"PeriodicalIF\":10.0000,\"publicationDate\":\"2024-10-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adhm.202470171\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advanced Healthcare Materials\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/adhm.202470171\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Healthcare Materials","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adhm.202470171","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}

引用次数: 0

摘要

抗体-特洛伊免疫转换器在 Yong Taik Lim 及其合作者发表的 2401270 号文章中，提出了一种程序化的两步激活策略，通过抗体-特洛伊免疫转换器共轭物增强癌症免疫疗法，并将全身毒性降到最低，该共轭物通过抗 SIRPα 特异性靶向髓系细胞，然后在抗体介导的内吞作用后重新激活瞬时失活的特洛伊 TLR7/8 激动剂。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

摘要图片

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Bioconjugated Antibody-Trojan Immune Converter Enhance Cancer Immunotherapy with Minimized Toxicity by Programmed Two-Step Immunomodulation of Myeloid Cells (Adv. Healthcare Mater. 27/2024)

Antibody-Trojan Immune Converter

In article 2401270 by Yong Taik Lim and co-worker, a programmed two-step activation strategy is suggested to enhance cancer immunotherapy with minimized systemic toxicities via Antibody-Trojan Immune Converter Conjugates that specifically targets myeloid cells by anti-SIRPα followed by reactivation of transiently inactivated Trojan TLR7/8 agonist after antibody-mediated endocytosis.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Advanced Healthcare Materials 工程技术-生物材料

CiteScore

14.40

自引率

3.00%

发文量

600

审稿时长

1.8 months

期刊介绍： Advanced Healthcare Materials, a distinguished member of the esteemed Advanced portfolio, has been dedicated to disseminating cutting-edge research on materials, devices, and technologies for enhancing human well-being for over ten years. As a comprehensive journal, it encompasses a wide range of disciplines such as biomaterials, biointerfaces, nanomedicine and nanotechnology, tissue engineering, and regenerative medicine.